{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:33:18Z","timestamp":1777653198218,"version":"3.51.4"},"reference-count":32,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2133\/dmpk.dmpk-12-rg-059","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T22:40:47Z","timestamp":1344897647000},"page":"125-131","source":"Crossref","is-referenced-by-count":6,"title":["Establishment of MDCKII Cell Monolayer with Metabolic Activity by CYP3A4 Transduced with Recombinant Adenovirus"],"prefix":"10.2133","volume":"28","author":[{"given":"Makoto","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshie","family":"Masaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0010","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1211\/jpp.59.10.0014","article-title":"Prediction of human pharmacokinetics\u2014improving microsome-based predictions of hepatic metabolic clearance","volume":"59","author":"Fagerholm","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0015","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1124\/dmd.110.032649","article-title":"Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data","volume":"38","author":"Gertz","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0020","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells","volume":"175","author":"Artursson","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms","volume":"15","author":"Dressman","year":"1998","journal-title":"Pharm. Res."},{"issue":"Suppl. 2","key":"10.2133\/dmpk.DMPK-12-RG-059_bb0030","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0928-0987(00)00181-0","article-title":"In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs","volume":"11","author":"Dressman","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0035","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1023\/A:1026107906191","article-title":"In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs","volume":"20","author":"Kataoka","year":"2003","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0168-3659(95)00147-6","article-title":"Intestinal drug metabolism and antitransport processes: A potential paradigm shift in oral drug delivery","volume":"39","author":"Benet","year":"1996","journal-title":"J. Control. Release"},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0045","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jps.21114","article-title":"Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane","volume":"97","author":"Shirasaka","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0050","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/jps.20691","article-title":"Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system","volume":"95","author":"Kataoka","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1248\/bpb.34.401","article-title":"In vitro dissolution\/permeation system to predict the oral absorption of poorly water-soluble drugs: effect of food and dose strength on it","volume":"34","author":"Kataoka","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0060","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s11095-011-0623-2","article-title":"Application of dissolution\/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development","volume":"29","author":"Kataoka","year":"2012","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0065","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejps.2011.09.007","article-title":"Estimation of P-glycoprotein-mediated efflux in the oral absorption of Pgp substrate drugs from simultaneous analysis of drug dissolution and permeation","volume":"44","author":"Kataoka","year":"2011","journal-title":"Eur J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0070","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \"pie\"","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0169-409X(96)00419-X","article-title":"Recombinant DNA technology as an investigative tool in drug metabolism research","volume":"22","author":"Friedberg","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/js9803205","article-title":"MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening","volume":"88","author":"Irvine","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0085","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1124\/jpet.103.056135","article-title":"Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers","volume":"307","author":"Siccardi","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2133\/dmpk.24.209","article-title":"Simultaneous expression of plural forms of human cytochrome P450 at desired ratios in HepG2 cells: adenovirus-mediated tool for cytochrome P450 reconstitution","volume":"24","author":"Aoyama","year":"2009","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0095","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1124\/dmd.110.033605","article-title":"Metabolite formation kinetics and intrinsic clearance of phenacetin, tolbutamide, alprazolam, and midazolam in adenoviral cytochrome P450-transfected HepG2 cells and comparison with hepatocytes and in vivo","volume":"38","author":"Donato","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0100","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.tiv.2009.11.020","article-title":"An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and gamma-glutamylcysteine synthe-tase knockdown cells","volume":"24","author":"Hosomi","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0105","first-page":"344","article-title":"CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells","volume":"24","author":"Gan","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0110","first-page":"1134","article-title":"First-pass midazolam metabolism catalyzed by 1alpha,25-dihydroxy vitamin D3- modified Caco-2 cell monolayers","volume":"289","author":"Fisher","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0115","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1023\/A:1010914624111","article-title":"Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate","volume":"18","author":"Cummins","year":"2001","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0120","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/A:1023433502647","article-title":"Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate","volume":"20","author":"Tolle-Sander","year":"2003","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1254\/jphs.10109FP","article-title":"Inhibition of P-glycoprotein-mediated efflux of digoxin and its metabolites by macrolide antibiotics","volume":"113","author":"Hughes","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0130","first-page":"1143","article-title":"Midazolam metabolism by modified Caco-2 monolayers: effects of extracellular protein binding","volume":"289","author":"Fisher","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0135","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1023\/A:1007599923694","article-title":"Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1\/ P-glycoprotein","volume":"17","author":"Brimer","year":"2000","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0140","first-page":"1552","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0009-9236(96)90162-9","article-title":"First-pass metabolism of midazolam by the human intestine","volume":"60","author":"Paine","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0150","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1124\/mol.51.5.741","article-title":"Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3","volume":"51","author":"Schmiedlin-Ren","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0155","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/jgm.552","article-title":"Hepatocyte growth factor stimulates adenoviral- mediated gene transfer across the apical membrane of epithelial cells","volume":"6","author":"Burrus","year":"2004","journal-title":"J. Gene Med."},{"key":"10.2133\/dmpk.DMPK-12-RG-059_bb0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715303906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715303906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T20:35:34Z","timestamp":1562099734000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715303906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1347436715303906"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.dmpk-12-rg-059","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}